Compare IVVD & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVVD | OLPX |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.7M | 680.9M |
| IPO Year | 2021 | 2021 |
| Metric | IVVD | OLPX |
|---|---|---|
| Price | $2.22 | $1.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.33 | $1.81 |
| AVG Volume (30 Days) | ★ 11.9M | 1.1M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $50,039,000.00 | ★ $418,582,000.00 |
| Revenue This Year | $103.88 | $1.94 |
| Revenue Next Year | $171.40 | $2.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 332.71 | N/A |
| 52 Week Low | $0.35 | $0.99 |
| 52 Week High | $3.07 | $2.28 |
| Indicator | IVVD | OLPX |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 55.79 |
| Support Level | $2.09 | $1.10 |
| Resistance Level | $2.60 | $1.16 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 41.67 | 88.75 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.